| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2275224C Process for making a polyalkenyl derivative of an unsaturated acidic reagent |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | US20080097112 Catalytic hydrogenation of C4-dicarboxylic acids in the gas phase using copper oxide and palladium on a support of oxides of Aluminum, Silicon, Zinc, Lanthanum, Cerium; chromium free |
| 04/24/2008 | US20080097111 Chemical intermediates of byproduct-free 7-thio-3H-isobenzofuran-1-one derivatives and herbicidal 7-[(4,6-dimethoxy-pyrimidin-2-yl)thio]-3-methyl-3H-isobenzo-furan-1-one |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 04/24/2008 | US20080096917 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | CA2666780A1 Novel inhibitors of chymase |
| 04/24/2008 | CA2665011A1 Alkylated heterocyclic reaction products useful as antioxidants |
| 04/23/2008 | EP1914313A1 Method for producing cercosporamide |
| 04/23/2008 | EP1914229A1 Novel cercosporamide derivative |
| 04/23/2008 | EP1913946A1 Therapeutic agent and treatment method for ameliorating uremia |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912963A2 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1534716B1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
| 04/23/2008 | CN101165060A Method for modifying heat-proof plasticizing methyl nadic anhydride |
| 04/23/2008 | CN100383254C Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents |
| 04/23/2008 | CN100383143C One-pot processing method for synthesizing rifampicin |
| 04/23/2008 | CN100383138C Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/22/2008 | US7361745 Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361459 Antiviral inhibition of capsid proteins |
| 04/22/2008 | US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight |
| 04/22/2008 | CA2265993C Novel antimicrobial cosmetic compositions |
| 04/17/2008 | WO2008044809A1 Method for preparing crystalline 3-0-alkyl-ascorbic acid |
| 04/17/2008 | WO2008044784A1 Taste-improving agent and food or drink containing the same |
| 04/17/2008 | WO2008044731A1 N-phenyloxamidic acid derivative |
| 04/17/2008 | WO2008044536A1 Bifunctional polymerizable compound, polymerizable liquid crystal composition, and oriented film |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | US20080090901 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-chagas chemoprophylactic and therapeutical activities |
| 04/17/2008 | US20080090900 Antibiotic bushrin |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/16/2008 | EP1911849A1 Prophylactic/ameliorating agent for menopausal disorder and functional beverage/food |
| 04/16/2008 | EP1911752A1 Process for the preparation of butyrolactones |
| 04/16/2008 | EP1911516A1 Homogeneous asymmetric hydrogenation catalyst |
| 04/16/2008 | EP1910325A2 New pharmaceutical compounds |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 04/16/2008 | EP1910275A2 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 04/16/2008 | EP1910273A2 10-substituted tetracyclines and methods of use thereof |
| 04/16/2008 | EP1789408B1 Androgen modulators |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | CN101163689A Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101163656A Catalysts for maleic acid hydrogenation to 1,4-butanediol |
| 04/16/2008 | CN101161647A Preparation method of vinylene carbonate for lithium ion-cell |
| 04/16/2008 | CN101161646A Ketones compound preventing cells from oxidation damage, preparation method and uses thereof |
| 04/16/2008 | CN101161645A Urea derivatives as well as preparation method and uses thereof |
| 04/16/2008 | CN101161625A Process for the reduction of sulfur, nitrogen and the production of useful oxygenates from hydrocarbon materials via one-pot selective oxidation |
| 04/16/2008 | CN100381431C Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358276 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/15/2008 | US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases |
| 04/15/2008 | US7358247 Mycophenolate mofetil impurity |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2337452C Process for the preparation of 4,5-diamino shikimic acid derivatives |
| 04/15/2008 | CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols |
| 04/15/2008 | CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect |
| 04/10/2008 | WO2008041826A1 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 04/10/2008 | WO2008041525A1 Furylmethylene malonamide compound and salt thereof, ultraviolet ray absorbent, and external preparation for skin |
| 04/10/2008 | WO2008041460A1 Active oxygen scavenger, activating agent and collagen production promoter each comprising cacalol |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2008040530A1 PROCESS FOR THE PREPARATION OF γ-BUTYROLACTONES |
| 04/10/2008 | WO2008040097A1 Furanone compounds and lactam analogues thereof |
| 04/10/2008 | WO2008040057A1 Novel benzofuran potassium channel blockers and uses thereof |
| 04/10/2008 | WO2008015638A3 New furyl thioalkanals useful in the flavor industry |
| 04/10/2008 | WO2007136640A3 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| 04/10/2008 | US20080085994 T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 04/10/2008 | US20080085993 Fluorescent Compounds |
| 04/10/2008 | US20080085928 such as N,N'-[hexane-1,6-diylbis(iminocarbonyl)]bis(3-chlorobenzenesulfonamide), used as Fructose-1,6-bisphosphatase inhibitors; metabolic disorders such as diabetes |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | CA2664857A1 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/09/2008 | EP1908756A1 Processes for preparation of crystalline mycophenolate sodium |
| 04/09/2008 | EP1907381A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1404661B1 Process for the production of 5-benzyl-3-furfuryl alcohol |
| 04/09/2008 | CN101160282A Acetylene derivatives |
| 04/09/2008 | CN101160124A Boron-containing small molecules |
| 04/09/2008 | CN101157676A Method for preparing costene lactone |
| 04/09/2008 | CN101157675A Two-set benzoic anhydride reaction device employing public air feeding system and operation method thereof |